Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Developmental Disabilities | 49 | 2024 | 201 | 10.310 |
Why?
|
Infant, Premature | 41 | 2024 | 295 | 7.560 |
Why?
|
Cerebral Palsy | 38 | 2024 | 95 | 6.980 |
Why?
|
Child Development | 31 | 2024 | 167 | 6.090 |
Why?
|
Disabled Children | 20 | 2018 | 43 | 4.010 |
Why?
|
Activities of Daily Living | 21 | 2024 | 207 | 3.930 |
Why?
|
Infant, Premature, Diseases | 13 | 2022 | 78 | 3.430 |
Why?
|
Infant, Newborn | 78 | 2024 | 2436 | 3.260 |
Why?
|
Child, Preschool | 86 | 2024 | 3661 | 3.140 |
Why?
|
Disabled Persons | 13 | 2024 | 71 | 2.840 |
Why?
|
Infant, Extremely Premature | 10 | 2024 | 28 | 2.460 |
Why?
|
Child | 89 | 2024 | 7065 | 2.450 |
Why?
|
Intellectual Disability | 15 | 2024 | 189 | 2.240 |
Why?
|
Disability Evaluation | 15 | 2020 | 138 | 2.160 |
Why?
|
Infant | 57 | 2024 | 3105 | 2.120 |
Why?
|
Parenting | 4 | 2022 | 67 | 2.010 |
Why?
|
Infant, Extremely Low Birth Weight | 6 | 2014 | 26 | 1.990 |
Why?
|
Premature Birth | 6 | 2018 | 115 | 1.870 |
Why?
|
Neuropsychological Tests | 18 | 2021 | 506 | 1.850 |
Why?
|
Retinopathy of Prematurity | 8 | 2023 | 66 | 1.810 |
Why?
|
Healthcare Disparities | 4 | 2017 | 390 | 1.730 |
Why?
|
Humans | 183 | 2024 | 87949 | 1.580 |
Why?
|
Child Welfare | 7 | 2018 | 39 | 1.570 |
Why?
|
Health Status Disparities | 3 | 2021 | 175 | 1.560 |
Why?
|
Health Services Accessibility | 6 | 2018 | 411 | 1.560 |
Why?
|
Intensive Care Units, Neonatal | 4 | 2024 | 69 | 1.400 |
Why?
|
Schools | 5 | 2022 | 74 | 1.370 |
Why?
|
Autism Spectrum Disorder | 6 | 2024 | 83 | 1.340 |
Why?
|
Adolescent | 51 | 2023 | 9111 | 1.340 |
Why?
|
Health Services Needs and Demand | 5 | 2018 | 103 | 1.290 |
Why?
|
Parent-Child Relations | 6 | 2024 | 79 | 1.280 |
Why?
|
Autistic Disorder | 4 | 2018 | 150 | 1.260 |
Why?
|
Transition to Adult Care | 3 | 2023 | 22 | 1.250 |
Why?
|
Female | 111 | 2024 | 45399 | 1.140 |
Why?
|
Education, Special | 6 | 2013 | 10 | 1.130 |
Why?
|
Tracheostomy | 2 | 2024 | 44 | 1.130 |
Why?
|
Motor Skills | 8 | 2020 | 79 | 1.110 |
Why?
|
Male | 104 | 2024 | 41697 | 1.110 |
Why?
|
Infant, Very Low Birth Weight | 9 | 2009 | 52 | 1.080 |
Why?
|
Gestational Age | 17 | 2024 | 315 | 1.080 |
Why?
|
Social Support | 7 | 2012 | 203 | 1.030 |
Why?
|
Home Care Services | 2 | 2017 | 72 | 1.020 |
Why?
|
Cognition Disorders | 7 | 2018 | 236 | 1.000 |
Why?
|
Quality of Life | 8 | 2024 | 1638 | 0.980 |
Why?
|
Mental Health | 6 | 2018 | 171 | 0.980 |
Why?
|
Language Development Disorders | 5 | 2018 | 24 | 0.940 |
Why?
|
Executive Function | 5 | 2018 | 87 | 0.900 |
Why?
|
Social Participation | 3 | 2018 | 14 | 0.880 |
Why?
|
Crime Victims | 3 | 2018 | 33 | 0.870 |
Why?
|
Down Syndrome | 6 | 2015 | 55 | 0.850 |
Why?
|
Motor Skills Disorders | 6 | 2018 | 15 | 0.850 |
Why?
|
Psychological Tests | 3 | 2018 | 91 | 0.830 |
Why?
|
Achondroplasia | 2 | 2012 | 8 | 0.820 |
Why?
|
Bronchopulmonary Dysplasia | 4 | 2024 | 42 | 0.810 |
Why?
|
Educational Status | 7 | 2022 | 191 | 0.800 |
Why?
|
Nervous System | 3 | 2020 | 87 | 0.790 |
Why?
|
Survivors | 3 | 2020 | 234 | 0.780 |
Why?
|
Employment | 4 | 2020 | 53 | 0.780 |
Why?
|
Residence Characteristics | 3 | 2016 | 193 | 0.770 |
Why?
|
Registries | 7 | 2024 | 743 | 0.770 |
Why?
|
Poverty | 3 | 2015 | 178 | 0.760 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2016 | 186 | 0.760 |
Why?
|
Potassium Channels, Inwardly Rectifying | 3 | 2016 | 121 | 0.750 |
Why?
|
International Classification of Functioning, Disability and Health | 1 | 2020 | 1 | 0.740 |
Why?
|
Family | 4 | 2020 | 316 | 0.720 |
Why?
|
Sleep Wake Disorders | 3 | 2016 | 117 | 0.710 |
Why?
|
Patient Discharge | 3 | 2022 | 311 | 0.700 |
Why?
|
Parents | 7 | 2024 | 281 | 0.700 |
Why?
|
Prevalence | 11 | 2024 | 1247 | 0.700 |
Why?
|
Self Care | 7 | 2012 | 164 | 0.680 |
Why?
|
Health Status | 10 | 2012 | 366 | 0.660 |
Why?
|
Child Protective Services | 1 | 2018 | 2 | 0.660 |
Why?
|
Academic Performance | 1 | 2018 | 7 | 0.650 |
Why?
|
Occupational Therapy | 1 | 2018 | 16 | 0.650 |
Why?
|
Motor Disorders | 1 | 2018 | 7 | 0.630 |
Why?
|
Referral and Consultation | 3 | 2019 | 339 | 0.630 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 31 | 0.610 |
Why?
|
United States | 19 | 2021 | 6809 | 0.610 |
Why?
|
Socioeconomic Factors | 14 | 2024 | 572 | 0.600 |
Why?
|
Adaptation, Psychological | 7 | 2018 | 162 | 0.600 |
Why?
|
Zika Virus | 3 | 2022 | 14 | 0.600 |
Why?
|
Zika Virus Infection | 3 | 2022 | 13 | 0.600 |
Why?
|
Family Characteristics | 2 | 2019 | 49 | 0.590 |
Why?
|
Independent Living | 2 | 2018 | 20 | 0.590 |
Why?
|
Metabolic Syndrome | 1 | 2018 | 128 | 0.590 |
Why?
|
Cognition | 6 | 2023 | 577 | 0.580 |
Why?
|
Nervous System Diseases | 7 | 2021 | 157 | 0.570 |
Why?
|
Risk Factors | 21 | 2024 | 5405 | 0.570 |
Why?
|
Social Skills | 3 | 2018 | 8 | 0.560 |
Why?
|
Patient Transfer | 1 | 2017 | 92 | 0.560 |
Why?
|
Psychological Trauma | 1 | 2016 | 8 | 0.560 |
Why?
|
Psychomotor Performance | 4 | 2021 | 494 | 0.550 |
Why?
|
Pregnancy | 16 | 2023 | 2974 | 0.530 |
Why?
|
Transitional Care | 1 | 2015 | 18 | 0.530 |
Why?
|
Longitudinal Studies | 11 | 2022 | 1037 | 0.530 |
Why?
|
Infant Behavior | 2 | 2013 | 5 | 0.520 |
Why?
|
Neurology | 2 | 2021 | 71 | 0.520 |
Why?
|
Child Abuse | 1 | 2016 | 81 | 0.520 |
Why?
|
Language | 1 | 2016 | 154 | 0.510 |
Why?
|
Weight Gain | 1 | 2015 | 121 | 0.490 |
Why?
|
Child Development Disorders, Pervasive | 2 | 2013 | 39 | 0.490 |
Why?
|
Diabetes Mellitus | 3 | 2016 | 743 | 0.480 |
Why?
|
Family Relations | 3 | 2019 | 35 | 0.480 |
Why?
|
Patient Reported Outcome Measures | 3 | 2024 | 186 | 0.470 |
Why?
|
Abnormalities, Multiple | 3 | 2015 | 233 | 0.470 |
Why?
|
Rett Syndrome | 5 | 2009 | 19 | 0.470 |
Why?
|
Delivery of Health Care | 4 | 2023 | 432 | 0.470 |
Why?
|
Psychomotor Disorders | 2 | 2012 | 20 | 0.460 |
Why?
|
Adult | 33 | 2024 | 26131 | 0.460 |
Why?
|
Prospective Studies | 18 | 2022 | 4247 | 0.450 |
Why?
|
Child Health Services | 3 | 2018 | 49 | 0.450 |
Why?
|
Cohort Studies | 14 | 2023 | 2802 | 0.440 |
Why?
|
Housing | 1 | 2012 | 43 | 0.420 |
Why?
|
Infant, Newborn, Diseases | 4 | 2022 | 111 | 0.420 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2012 | 7 | 0.420 |
Why?
|
Surveys and Questionnaires | 13 | 2024 | 2574 | 0.410 |
Why?
|
Health Promotion | 2 | 2019 | 158 | 0.410 |
Why?
|
Length of Stay | 1 | 2015 | 716 | 0.410 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 697 | 0.410 |
Why?
|
Interpersonal Relations | 4 | 2020 | 174 | 0.410 |
Why?
|
Neurodevelopmental Disorders | 3 | 2024 | 38 | 0.410 |
Why?
|
Professional-Family Relations | 1 | 2012 | 48 | 0.400 |
Why?
|
Obesity | 1 | 2018 | 957 | 0.400 |
Why?
|
Population Surveillance | 4 | 2010 | 216 | 0.400 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 1682 | 0.390 |
Why?
|
Child Behavior | 3 | 2010 | 48 | 0.390 |
Why?
|
Pediatrics | 2 | 2013 | 350 | 0.390 |
Why?
|
Physician's Role | 1 | 2013 | 176 | 0.390 |
Why?
|
Health Status Indicators | 5 | 2012 | 104 | 0.380 |
Why?
|
Follow-Up Studies | 17 | 2020 | 3650 | 0.380 |
Why?
|
Birth Weight | 5 | 2012 | 145 | 0.370 |
Why?
|
Interviews as Topic | 1 | 2012 | 333 | 0.370 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2022 | 110 | 0.370 |
Why?
|
Bioethics | 1 | 2011 | 35 | 0.370 |
Why?
|
Australia | 4 | 2021 | 102 | 0.360 |
Why?
|
Genetic Testing | 2 | 2012 | 534 | 0.360 |
Why?
|
Attention | 1 | 2014 | 390 | 0.360 |
Why?
|
Neonatal Screening | 5 | 2012 | 60 | 0.350 |
Why?
|
Severity of Illness Index | 13 | 2024 | 1827 | 0.340 |
Why?
|
Social Environment | 2 | 2007 | 187 | 0.340 |
Why?
|
Central Nervous System | 1 | 2010 | 152 | 0.340 |
Why?
|
Treatment Outcome | 7 | 2018 | 8104 | 0.330 |
Why?
|
Child Nutrition Disorders | 1 | 2008 | 12 | 0.330 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 333 | 0.330 |
Why?
|
Young Adult | 9 | 2024 | 6151 | 0.320 |
Why?
|
Ventilators, Mechanical | 3 | 2024 | 37 | 0.320 |
Why?
|
Behavior Therapy | 1 | 2009 | 83 | 0.320 |
Why?
|
Brain | 5 | 2016 | 2254 | 0.320 |
Why?
|
Infant Mortality | 2 | 2007 | 59 | 0.320 |
Why?
|
Aging | 1 | 2013 | 702 | 0.310 |
Why?
|
Sensation Disorders | 1 | 2007 | 23 | 0.310 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 642 | 0.300 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2008 | 46 | 0.300 |
Why?
|
Practice Patterns, Physicians' | 1 | 2013 | 593 | 0.300 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 2316 | 0.300 |
Why?
|
Child of Impaired Parents | 1 | 2007 | 19 | 0.300 |
Why?
|
Morbidity | 2 | 2001 | 147 | 0.290 |
Why?
|
Mothers | 3 | 2019 | 143 | 0.290 |
Why?
|
Clinical Competence | 1 | 2013 | 777 | 0.290 |
Why?
|
Congenital Abnormalities | 2 | 1999 | 63 | 0.290 |
Why?
|
Preventive Health Services | 1 | 2007 | 39 | 0.290 |
Why?
|
Developing Countries | 1 | 2007 | 72 | 0.290 |
Why?
|
Deglutition Disorders | 5 | 1994 | 118 | 0.280 |
Why?
|
Regression Analysis | 7 | 2014 | 594 | 0.280 |
Why?
|
Cardiac Surgical Procedures | 1 | 2011 | 473 | 0.280 |
Why?
|
Movement | 3 | 2022 | 303 | 0.280 |
Why?
|
Mutation | 4 | 2016 | 4078 | 0.280 |
Why?
|
Magnetic Resonance Imaging | 6 | 2016 | 3425 | 0.280 |
Why?
|
Practice Guidelines as Topic | 3 | 2011 | 1024 | 0.270 |
Why?
|
Medical Oncology | 1 | 2010 | 374 | 0.270 |
Why?
|
Respiration, Artificial | 3 | 2024 | 347 | 0.270 |
Why?
|
Analysis of Variance | 7 | 2012 | 901 | 0.270 |
Why?
|
Psychometrics | 4 | 2012 | 328 | 0.270 |
Why?
|
Sick Role | 1 | 2005 | 13 | 0.270 |
Why?
|
Social Adjustment | 1 | 2005 | 47 | 0.260 |
Why?
|
Genetic Diseases, Inborn | 2 | 2012 | 101 | 0.260 |
Why?
|
Meningomyelocele | 1 | 2005 | 21 | 0.260 |
Why?
|
Respiratory Distress Syndrome, Newborn | 3 | 2010 | 54 | 0.260 |
Why?
|
White Matter | 2 | 2016 | 82 | 0.260 |
Why?
|
Epilepsy | 4 | 2013 | 417 | 0.260 |
Why?
|
Infant, Low Birth Weight | 3 | 2000 | 57 | 0.260 |
Why?
|
Brain Diseases | 1 | 2006 | 184 | 0.250 |
Why?
|
Time Factors | 6 | 2018 | 5284 | 0.250 |
Why?
|
Risk | 3 | 2016 | 660 | 0.250 |
Why?
|
Mother-Child Relations | 2 | 2019 | 26 | 0.240 |
Why?
|
Health Services | 2 | 2003 | 56 | 0.240 |
Why?
|
Anxiety Disorders | 2 | 2023 | 151 | 0.240 |
Why?
|
Brain Neoplasms | 1 | 2010 | 773 | 0.240 |
Why?
|
Fish Products | 1 | 2003 | 3 | 0.230 |
Why?
|
Canada | 2 | 2021 | 206 | 0.230 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2003 | 3 | 0.230 |
Why?
|
Feasibility Studies | 3 | 2024 | 769 | 0.230 |
Why?
|
Maternal Exposure | 1 | 2003 | 58 | 0.220 |
Why?
|
Mobile Applications | 1 | 2024 | 66 | 0.220 |
Why?
|
Vision Disorders | 3 | 2014 | 75 | 0.210 |
Why?
|
Students | 2 | 2009 | 162 | 0.210 |
Why?
|
Intestinal Perforation | 1 | 2022 | 35 | 0.210 |
Why?
|
Microcephaly | 1 | 2022 | 76 | 0.210 |
Why?
|
Life Change Events | 1 | 2022 | 48 | 0.210 |
Why?
|
Bevacizumab | 2 | 2023 | 285 | 0.200 |
Why?
|
Water Pollutants, Chemical | 1 | 2003 | 135 | 0.200 |
Why?
|
Self Concept | 2 | 2021 | 132 | 0.200 |
Why?
|
Social Class | 4 | 2024 | 134 | 0.200 |
Why?
|
New York | 5 | 2009 | 69 | 0.200 |
Why?
|
Pain | 1 | 2024 | 395 | 0.200 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2022 | 79 | 0.200 |
Why?
|
Chronic Pain | 1 | 2023 | 157 | 0.190 |
Why?
|
Clostridiales | 1 | 2021 | 18 | 0.190 |
Why?
|
Quality Indicators, Health Care | 1 | 2022 | 146 | 0.190 |
Why?
|
Sepsis | 1 | 2004 | 313 | 0.190 |
Why?
|
Bacteroidetes | 1 | 2021 | 37 | 0.190 |
Why?
|
Emotions | 2 | 2023 | 348 | 0.190 |
Why?
|
Communication Disorders | 1 | 2000 | 7 | 0.190 |
Why?
|
Checklist | 1 | 2021 | 57 | 0.180 |
Why?
|
Attitude to Health | 2 | 2003 | 221 | 0.180 |
Why?
|
Video Recording | 4 | 2024 | 197 | 0.180 |
Why?
|
Public Policy | 3 | 2011 | 53 | 0.180 |
Why?
|
Patient Care | 1 | 2021 | 101 | 0.180 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 164 | 0.180 |
Why?
|
Chronic Disease | 1 | 2003 | 942 | 0.170 |
Why?
|
Siblings | 2 | 2016 | 110 | 0.170 |
Why?
|
Mental Disorders | 1 | 2023 | 405 | 0.170 |
Why?
|
Medical Marijuana | 1 | 2019 | 7 | 0.170 |
Why?
|
Pregnancy, Multiple | 1 | 2018 | 37 | 0.170 |
Why?
|
Laser Coagulation | 1 | 2019 | 54 | 0.170 |
Why?
|
Telemedicine | 1 | 2021 | 176 | 0.160 |
Why?
|
Literacy | 1 | 2018 | 2 | 0.160 |
Why?
|
Term Birth | 1 | 2018 | 8 | 0.160 |
Why?
|
Health Surveys | 3 | 2007 | 239 | 0.160 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 337 | 0.160 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 3 | 1988 | 11 | 0.160 |
Why?
|
Sex Factors | 4 | 2018 | 1059 | 0.160 |
Why?
|
Achievement | 2 | 2012 | 29 | 0.160 |
Why?
|
Social Determinants of Health | 1 | 2019 | 89 | 0.160 |
Why?
|
Depression | 2 | 2015 | 492 | 0.160 |
Why?
|
Child Health | 1 | 2018 | 11 | 0.150 |
Why?
|
Counseling | 1 | 2019 | 159 | 0.150 |
Why?
|
Health Policy | 2 | 2010 | 184 | 0.150 |
Why?
|
Reproducibility of Results | 7 | 2021 | 2740 | 0.150 |
Why?
|
Probability | 1 | 2018 | 356 | 0.150 |
Why?
|
Depressive Disorder | 1 | 2018 | 223 | 0.150 |
Why?
|
Comorbidity | 2 | 2013 | 941 | 0.150 |
Why?
|
Statistics, Nonparametric | 2 | 2012 | 307 | 0.150 |
Why?
|
Health Behavior | 1 | 2018 | 183 | 0.140 |
Why?
|
Lipids | 1 | 2018 | 269 | 0.140 |
Why?
|
Legal Guardians | 1 | 2016 | 7 | 0.140 |
Why?
|
Chicago | 2 | 2024 | 1397 | 0.140 |
Why?
|
Urea | 2 | 1988 | 58 | 0.140 |
Why?
|
Angiogenesis Inhibitors | 1 | 2019 | 313 | 0.140 |
Why?
|
Health Personnel | 1 | 2019 | 207 | 0.140 |
Why?
|
Hospitals, University | 2 | 2016 | 195 | 0.140 |
Why?
|
Hypothermia | 1 | 2016 | 26 | 0.140 |
Why?
|
Patient Participation | 1 | 2018 | 219 | 0.140 |
Why?
|
Erythropoietin | 1 | 2016 | 89 | 0.130 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 141 | 0.130 |
Why?
|
Multicenter Studies as Topic | 2 | 2006 | 155 | 0.130 |
Why?
|
Retrospective Studies | 9 | 2024 | 8780 | 0.130 |
Why?
|
Child Behavior Disorders | 1 | 2016 | 76 | 0.130 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2016 | 53 | 0.130 |
Why?
|
Mass Screening | 3 | 2010 | 627 | 0.130 |
Why?
|
Exercise | 1 | 2018 | 318 | 0.130 |
Why?
|
Ear | 1 | 1995 | 18 | 0.130 |
Why?
|
Sexual Behavior | 2 | 2016 | 307 | 0.130 |
Why?
|
Body Mass Index | 1 | 2018 | 765 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 834 | 0.120 |
Why?
|
Pregnancy in Diabetics | 1 | 1995 | 38 | 0.120 |
Why?
|
Self Report | 1 | 2016 | 294 | 0.120 |
Why?
|
Inhalation | 2 | 1994 | 31 | 0.120 |
Why?
|
Neurologic Examination | 5 | 2013 | 119 | 0.120 |
Why?
|
Logistic Models | 5 | 2018 | 1200 | 0.120 |
Why?
|
Stress, Psychological | 3 | 2008 | 320 | 0.120 |
Why?
|
Visual Fields | 1 | 2014 | 98 | 0.120 |
Why?
|
Blood Pressure | 1 | 2018 | 885 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2022 | 59 | 0.120 |
Why?
|
Ocular Motility Disorders | 1 | 2014 | 18 | 0.120 |
Why?
|
Spine | 1 | 1995 | 100 | 0.120 |
Why?
|
Gastrointestinal Microbiome | 1 | 2021 | 482 | 0.120 |
Why?
|
Functional Laterality | 1 | 2015 | 201 | 0.120 |
Why?
|
Fixation, Ocular | 1 | 2014 | 48 | 0.120 |
Why?
|
Aftercare | 2 | 2022 | 86 | 0.120 |
Why?
|
Communication | 2 | 2012 | 448 | 0.120 |
Why?
|
Emotional Intelligence | 1 | 2013 | 22 | 0.110 |
Why?
|
North America | 2 | 2024 | 184 | 0.110 |
Why?
|
Metabolism, Inborn Errors | 2 | 2003 | 30 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2016 | 1843 | 0.110 |
Why?
|
Phenotype | 6 | 2013 | 2424 | 0.110 |
Why?
|
Adaptation, Physiological | 2 | 2012 | 314 | 0.110 |
Why?
|
Hospitalization | 2 | 2017 | 864 | 0.110 |
Why?
|
Censuses | 1 | 2012 | 6 | 0.110 |
Why?
|
Pilot Projects | 2 | 2012 | 861 | 0.110 |
Why?
|
Cryotherapy | 2 | 2004 | 30 | 0.110 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 1697 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2012 | 36 | 0.110 |
Why?
|
Learning | 2 | 2021 | 283 | 0.110 |
Why?
|
Mortality | 1 | 1993 | 150 | 0.100 |
Why?
|
Cerebellar Neoplasms | 1 | 2012 | 36 | 0.100 |
Why?
|
Sulfonylurea Compounds | 1 | 2012 | 62 | 0.100 |
Why?
|
Telephone | 1 | 2012 | 35 | 0.100 |
Why?
|
Ultrasonography | 3 | 2014 | 703 | 0.100 |
Why?
|
Language Development | 1 | 2012 | 23 | 0.100 |
Why?
|
Radiotherapy, Conformal | 1 | 2012 | 84 | 0.100 |
Why?
|
Hearing Loss | 2 | 2019 | 58 | 0.100 |
Why?
|
Wheelchairs | 1 | 1991 | 9 | 0.100 |
Why?
|
Motor Activity | 2 | 2009 | 328 | 0.100 |
Why?
|
Transportation | 1 | 1991 | 19 | 0.100 |
Why?
|
Enteral Nutrition | 3 | 2021 | 103 | 0.100 |
Why?
|
Health Care Surveys | 1 | 2012 | 280 | 0.100 |
Why?
|
Multivariate Analysis | 4 | 2024 | 994 | 0.100 |
Why?
|
International Cooperation | 1 | 2011 | 123 | 0.090 |
Why?
|
Patient-Centered Care | 1 | 2013 | 206 | 0.090 |
Why?
|
Leukomalacia, Periventricular | 3 | 2009 | 18 | 0.090 |
Why?
|
Family Health | 2 | 2008 | 162 | 0.090 |
Why?
|
Science | 1 | 2011 | 34 | 0.090 |
Why?
|
Diagnosis, Differential | 5 | 2010 | 1586 | 0.090 |
Why?
|
Rhode Island | 2 | 2007 | 10 | 0.090 |
Why?
|
Victoria | 1 | 2010 | 5 | 0.090 |
Why?
|
Atlanto-Axial Joint | 1 | 1990 | 8 | 0.090 |
Why?
|
Vasodilator Agents | 1 | 2010 | 144 | 0.090 |
Why?
|
Research | 1 | 2011 | 250 | 0.090 |
Why?
|
Incidence | 3 | 2012 | 1580 | 0.090 |
Why?
|
Neural Tube Defects | 2 | 2004 | 43 | 0.090 |
Why?
|
Reading | 1 | 2009 | 31 | 0.090 |
Why?
|
Maternal Age | 2 | 2024 | 45 | 0.090 |
Why?
|
Allied Health Occupations | 1 | 2009 | 1 | 0.090 |
Why?
|
Nitric Oxide | 1 | 2010 | 278 | 0.080 |
Why?
|
Psychology | 1 | 2009 | 24 | 0.080 |
Why?
|
Communication Aids for Disabled | 1 | 2008 | 4 | 0.080 |
Why?
|
Faculty | 1 | 2009 | 32 | 0.080 |
Why?
|
Joint Instability | 1 | 1990 | 82 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2014 | 157 | 0.080 |
Why?
|
Professional Role | 1 | 2009 | 41 | 0.080 |
Why?
|
Blindness | 3 | 1994 | 41 | 0.080 |
Why?
|
Caffeine | 1 | 1989 | 83 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2012 | 474 | 0.080 |
Why?
|
Psychology, Adolescent | 1 | 2008 | 29 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2009 | 124 | 0.080 |
Why?
|
Physical Therapy Modalities | 1 | 2008 | 83 | 0.080 |
Why?
|
Prognosis | 2 | 2010 | 3729 | 0.080 |
Why?
|
Clinical Nursing Research | 1 | 2007 | 3 | 0.080 |
Why?
|
Pediatric Nursing | 1 | 2007 | 6 | 0.080 |
Why?
|
House Calls | 1 | 2007 | 9 | 0.080 |
Why?
|
Nursing Assessment | 1 | 2007 | 20 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 25477 | 0.080 |
Why?
|
Single Parent | 1 | 2007 | 3 | 0.070 |
Why?
|
Psychosocial Deprivation | 1 | 2007 | 4 | 0.070 |
Why?
|
Women's Health | 1 | 2008 | 102 | 0.070 |
Why?
|
Interview, Psychological | 1 | 2007 | 69 | 0.070 |
Why?
|
Pharynx | 4 | 1994 | 45 | 0.070 |
Why?
|
Videotape Recording | 1 | 2006 | 47 | 0.070 |
Why?
|
Gender Identity | 1 | 2007 | 53 | 0.070 |
Why?
|
Decision Making | 1 | 2012 | 655 | 0.070 |
Why?
|
Fluoroscopy | 4 | 1994 | 122 | 0.070 |
Why?
|
Health Education | 1 | 2007 | 101 | 0.070 |
Why?
|
Age Factors | 5 | 2009 | 1853 | 0.070 |
Why?
|
Cost of Illness | 1 | 2007 | 147 | 0.070 |
Why?
|
Genomics | 1 | 2012 | 740 | 0.070 |
Why?
|
Risk Assessment | 3 | 2022 | 2274 | 0.070 |
Why?
|
Deglutition | 4 | 1994 | 76 | 0.070 |
Why?
|
Fathers | 1 | 2007 | 70 | 0.070 |
Why?
|
Aphasia | 1 | 1986 | 15 | 0.070 |
Why?
|
Cerebral Hemorrhage | 1 | 2009 | 334 | 0.070 |
Why?
|
Disease Progression | 1 | 2010 | 1479 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 2019 | 0.060 |
Why?
|
Caregivers | 1 | 2006 | 155 | 0.060 |
Why?
|
Maternal Health | 1 | 2024 | 2 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2005 | 235 | 0.060 |
Why?
|
Intelligence | 2 | 2018 | 71 | 0.060 |
Why?
|
Food, Fortified | 1 | 2004 | 14 | 0.060 |
Why?
|
Cocaine | 2 | 1998 | 76 | 0.060 |
Why?
|
Walking | 2 | 2005 | 89 | 0.060 |
Why?
|
Folic Acid | 1 | 2004 | 62 | 0.060 |
Why?
|
Fresh Water | 1 | 2003 | 20 | 0.060 |
Why?
|
Food Contamination | 1 | 2003 | 32 | 0.060 |
Why?
|
Fetal Development | 1 | 2003 | 32 | 0.060 |
Why?
|
Pregnancy Trimester, First | 1 | 2003 | 63 | 0.060 |
Why?
|
Intelligence Tests | 2 | 2018 | 38 | 0.060 |
Why?
|
Lower Extremity | 1 | 2023 | 87 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2004 | 128 | 0.050 |
Why?
|
Brain Injuries | 2 | 2016 | 162 | 0.050 |
Why?
|
Muscle Spasticity | 1 | 2022 | 9 | 0.050 |
Why?
|
Smartphone | 1 | 2023 | 39 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2003 | 59 | 0.050 |
Why?
|
Life Style | 1 | 2003 | 172 | 0.050 |
Why?
|
Pain Measurement | 1 | 2023 | 328 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 2516 | 0.050 |
Why?
|
Television | 2 | 1999 | 29 | 0.050 |
Why?
|
Internet | 1 | 2024 | 317 | 0.050 |
Why?
|
Observational Studies as Topic | 1 | 2021 | 49 | 0.050 |
Why?
|
Pregnancy Outcome | 1 | 2003 | 252 | 0.050 |
Why?
|
Negotiating | 1 | 2021 | 20 | 0.050 |
Why?
|
New Zealand | 1 | 2001 | 22 | 0.050 |
Why?
|
Respite Care | 1 | 2001 | 9 | 0.050 |
Why?
|
Sweden | 1 | 2001 | 40 | 0.050 |
Why?
|
Social Behavior | 1 | 2004 | 297 | 0.050 |
Why?
|
Intensive Care, Neonatal | 1 | 2020 | 13 | 0.050 |
Why?
|
Genetics, Behavioral | 1 | 2000 | 22 | 0.050 |
Why?
|
New England | 1 | 2000 | 10 | 0.050 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 219 | 0.050 |
Why?
|
Patient Admission | 1 | 2001 | 113 | 0.050 |
Why?
|
Alberta | 1 | 2020 | 8 | 0.050 |
Why?
|
Colombia | 1 | 2020 | 11 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2002 | 219 | 0.050 |
Why?
|
Delivery, Obstetric | 1 | 2021 | 117 | 0.050 |
Why?
|
Head | 1 | 2021 | 135 | 0.040 |
Why?
|
Nervous System Malformations | 1 | 2020 | 46 | 0.040 |
Why?
|
Needs Assessment | 1 | 2001 | 156 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2022 | 252 | 0.040 |
Why?
|
Visual Acuity | 1 | 2000 | 196 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2016 | 1711 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2003 | 415 | 0.040 |
Why?
|
Vision, Low | 1 | 2019 | 15 | 0.040 |
Why?
|
Intravitreal Injections | 1 | 2019 | 69 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2013 | 1703 | 0.040 |
Why?
|
Pregnancy, Twin | 1 | 2018 | 7 | 0.040 |
Why?
|
Feces | 1 | 2021 | 326 | 0.040 |
Why?
|
Failure to Thrive | 1 | 1998 | 17 | 0.040 |
Why?
|
Academic Success | 1 | 2018 | 11 | 0.040 |
Why?
|
Fetal Alcohol Spectrum Disorders | 1 | 1998 | 2 | 0.040 |
Why?
|
Asphyxia Neonatorum | 1 | 1998 | 7 | 0.040 |
Why?
|
Body Height | 1 | 1998 | 100 | 0.040 |
Why?
|
Models, Biological | 1 | 2005 | 1759 | 0.040 |
Why?
|
Narcotics | 1 | 1998 | 69 | 0.040 |
Why?
|
Hypoxia | 2 | 1993 | 649 | 0.040 |
Why?
|
Inflammation | 1 | 2023 | 951 | 0.040 |
Why?
|
Oxygen | 1 | 2022 | 741 | 0.040 |
Why?
|
Odds Ratio | 1 | 2019 | 682 | 0.040 |
Why?
|
Barium Sulfate | 2 | 1994 | 43 | 0.040 |
Why?
|
Body Weight | 1 | 1998 | 451 | 0.040 |
Why?
|
Seizures | 2 | 2013 | 306 | 0.040 |
Why?
|
Pneumonia, Aspiration | 2 | 1994 | 19 | 0.040 |
Why?
|
Survival Analysis | 1 | 2000 | 1539 | 0.040 |
Why?
|
Neurologic Manifestations | 1 | 2016 | 11 | 0.040 |
Why?
|
Methyl-CpG-Binding Protein 2 | 2 | 2009 | 16 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 360 | 0.030 |
Why?
|
Food | 2 | 1994 | 86 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2016 | 241 | 0.030 |
Why?
|
Electroencephalography | 2 | 2013 | 739 | 0.030 |
Why?
|
Pandemics | 1 | 2021 | 757 | 0.030 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 2 | 1986 | 4 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 765 | 0.030 |
Why?
|
Visual Perception | 1 | 2018 | 322 | 0.030 |
Why?
|
Ammonia | 2 | 1986 | 38 | 0.030 |
Why?
|
Hearing Loss, Bilateral | 1 | 1995 | 10 | 0.030 |
Why?
|
Visual Field Tests | 1 | 2014 | 14 | 0.030 |
Why?
|
Neural Crest | 1 | 1995 | 27 | 0.030 |
Why?
|
Acidosis | 1 | 2014 | 55 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2016 | 276 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 2014 | 77 | 0.030 |
Why?
|
Mesoderm | 1 | 1995 | 121 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 900 | 0.030 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 1995 | 75 | 0.030 |
Why?
|
Cineradiography | 1 | 1994 | 25 | 0.030 |
Why?
|
Hypoglycemia | 1 | 1995 | 105 | 0.030 |
Why?
|
Pulmonary Surfactants | 1 | 1994 | 19 | 0.030 |
Why?
|
Mouth | 1 | 1994 | 48 | 0.030 |
Why?
|
Projection | 1 | 1993 | 1 | 0.030 |
Why?
|
Databases, Factual | 2 | 2011 | 839 | 0.030 |
Why?
|
Aspirin | 1 | 2014 | 157 | 0.030 |
Why?
|
Gastrostomy | 1 | 1994 | 69 | 0.030 |
Why?
|
Orientation | 1 | 2014 | 119 | 0.030 |
Why?
|
Placenta | 1 | 2014 | 178 | 0.030 |
Why?
|
Survival Rate | 1 | 1997 | 1877 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2012 | 40 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 242 | 0.030 |
Why?
|
Retina | 1 | 2014 | 214 | 0.030 |
Why?
|
World Health Organization | 1 | 2012 | 104 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2014 | 343 | 0.020 |
Why?
|
Induction Chemotherapy | 1 | 2012 | 149 | 0.020 |
Why?
|
Spinal Cord Compression | 1 | 1991 | 27 | 0.020 |
Why?
|
Spinal Stenosis | 1 | 1991 | 25 | 0.020 |
Why?
|
Safety | 1 | 1991 | 151 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1991 | 80 | 0.020 |
Why?
|
Multiple Sclerosis | 1 | 1993 | 264 | 0.020 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1990 | 20 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2010 | 188 | 0.020 |
Why?
|
Acetaminophen | 1 | 1990 | 55 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2009 | 25 | 0.020 |
Why?
|
Xanthines | 1 | 1989 | 3 | 0.020 |
Why?
|
Reoperation | 1 | 2012 | 605 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2012 | 1210 | 0.020 |
Why?
|
Uracil | 1 | 1989 | 56 | 0.020 |
Why?
|
Brain Damage, Chronic | 2 | 1991 | 26 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1995 | 561 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2009 | 225 | 0.020 |
Why?
|
Acetylation | 1 | 1989 | 126 | 0.020 |
Why?
|
Kidney | 1 | 1995 | 1140 | 0.020 |
Why?
|
Scoliosis | 1 | 2009 | 31 | 0.020 |
Why?
|
Fetus | 1 | 1990 | 230 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 113 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1989 | 315 | 0.020 |
Why?
|
Arm | 1 | 1988 | 96 | 0.020 |
Why?
|
Education of Intellectually Disabled | 1 | 1987 | 2 | 0.020 |
Why?
|
Coma | 2 | 1986 | 44 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 1987 | 20 | 0.020 |
Why?
|
Comprehensive Health Care | 1 | 1987 | 13 | 0.020 |
Why?
|
ROC Curve | 1 | 2009 | 769 | 0.020 |
Why?
|
Observer Variation | 2 | 2000 | 607 | 0.020 |
Why?
|
Movement Disorders | 1 | 2006 | 44 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 1347 | 0.020 |
Why?
|
Paralysis | 1 | 2005 | 22 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2006 | 123 | 0.020 |
Why?
|
Muscle Hypotonia | 1 | 2005 | 45 | 0.020 |
Why?
|
Heterozygote | 1 | 1986 | 369 | 0.020 |
Why?
|
Argininosuccinate Synthase | 1 | 1984 | 1 | 0.020 |
Why?
|
Argininosuccinic Aciduria | 1 | 1984 | 1 | 0.020 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 1984 | 4 | 0.020 |
Why?
|
Anencephaly | 1 | 2004 | 7 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 1866 | 0.010 |
Why?
|
Spinal Dysraphism | 1 | 2004 | 19 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2003 | 222 | 0.010 |
Why?
|
Biotinidase Deficiency | 1 | 2002 | 1 | 0.010 |
Why?
|
Homocystinuria | 1 | 2002 | 2 | 0.010 |
Why?
|
Galactosemias | 1 | 2002 | 3 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2003 | 190 | 0.010 |
Why?
|
Maple Syrup Urine Disease | 1 | 2002 | 5 | 0.010 |
Why?
|
Western Australia | 1 | 2002 | 2 | 0.010 |
Why?
|
Oximetry | 2 | 1993 | 84 | 0.010 |
Why?
|
Education | 1 | 2000 | 57 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1990 | 2246 | 0.010 |
Why?
|
Protein-Energy Malnutrition | 1 | 1998 | 5 | 0.010 |
Why?
|
Anthropometry | 1 | 1998 | 75 | 0.010 |
Why?
|
Sex Distribution | 1 | 1997 | 172 | 0.010 |
Why?
|
Age Distribution | 1 | 1997 | 200 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 1224 | 0.010 |
Why?
|
Fontan Procedure | 1 | 1995 | 55 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1996 | 491 | 0.010 |
Why?
|
Velopharyngeal Insufficiency | 1 | 1994 | 3 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1984 | 2624 | 0.010 |
Why?
|
Barium | 1 | 1993 | 31 | 0.010 |
Why?
|
Cough | 1 | 1993 | 55 | 0.010 |
Why?
|
Gastroesophageal Reflux | 1 | 1994 | 120 | 0.010 |
Why?
|
Airway Obstruction | 1 | 1993 | 110 | 0.010 |
Why?
|
Patient Care Team | 1 | 1994 | 282 | 0.010 |
Why?
|
Intervertebral Disc Displacement | 1 | 1991 | 22 | 0.010 |
Why?
|
Respiration | 1 | 1993 | 266 | 0.010 |
Why?
|
Heart Rate | 1 | 1993 | 492 | 0.010 |
Why?
|
Spinal Cord | 1 | 1991 | 250 | 0.010 |
Why?
|
Algorithms | 1 | 1997 | 1857 | 0.010 |
Why?
|
Administration, Oral | 1 | 1990 | 680 | 0.010 |
Why?
|
Dyslexia | 1 | 1988 | 11 | 0.010 |
Why?
|
Genetic Carrier Screening | 1 | 1986 | 60 | 0.000 |
Why?
|
Substance-Related Disorders | 1 | 1990 | 407 | 0.000 |
Why?
|
X Chromosome | 1 | 1986 | 152 | 0.000 |
Why?
|
Aged | 2 | 1994 | 18750 | 0.000 |
Why?
|
Genetic Linkage | 1 | 1986 | 623 | 0.000 |
Why?
|
Pedigree | 1 | 1986 | 968 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1991 | 6655 | 0.000 |
Why?
|